Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Briviact® (brivaracetam) – Expanded indication
August 30, 2021 - UCB announced the FDA approval of Briviact (brivaracetam), for the treatment of partial-onset seizures in patients 1 month of age and older.
